Peroxiben

Quick links to important sections

Peroxiben

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Peroxiben

What is Peroxiben?

Peroxiben is a topical medication primarily used for the local treatment of acne vulgaris. It is formulated as a gel and belongs to a class of medications known as anti-acne preparations for topical use.

Active Ingredient and Mechanism

The active substance in Peroxiben is benzoyl peroxide. This compound functions through several distinct mechanisms to address the symptoms of acne:

  • Antimicrobial Action: It exhibits oxidizing properties that reduce the population of Cutibacterium acnes, the bacteria often associated with the inflammation of acne lesions.
  • Sebostatic Effect: It helps to regulate and reduce the production of excess sebum, the oily substance produced by the skin's sebaceous glands.
  • Keratolytic Action: It promotes the softening and peeling of the outer layer of the skin, which helps to clear pores and prevent the formation of comedones (whiteheads and blackheads).

Clinical Applications

Peroxiben is indicated for the treatment of mild to moderate acne in adults and adolescents. By targeting the bacterial, inflammatory, and obstructive components of acne, it helps to improve the overall appearance of the skin and reduce the frequency of breakouts.

Unlike topical antibiotics, benzoyl peroxide does not induce bacterial resistance, making it a common choice for long-term management of acne symptoms. It is available in different concentrations to allow for adjustments based on individual skin sensitivity and the severity of the condition.

Regulatory References

  1. NIH: StatPearls, Benzoyl Peroxide
  2. World Health Organization's List of Essential Medicines (WHO)

What side effects are possible with Peroxiben?

Possible Side Effects and Safety Information

The safety profile for topical Benzoyl Peroxide (the active ingredient in Peroxiben) is characterized by reactions primarily affecting the skin, as documented in official regulatory sources like the EMA SmPC and FDA labeling.


Frequency-Classified Adverse Reactions

The majority of effects fall under the Skin and subcutaneous tissue disorders System-Organ-Class. These reactions follow regulatory frequency categories:

  • Very Common (affecting ge 1 in 10 users): Localized erythema (redness), dry skin (xerosis), peeling (desquamation), and a burning/stinging sensation at the application site.
  • Common (affecting ge 1 in 100 users): Pruritus (itching).
  • Uncommon (affecting ge 1 in 1,000 users): Allergic contact dermatitis.

Time-Related Patterns and Serious Reactions

The regulatory documentation notes that common adverse effects, such as irritation and redness, are more likely to appear at the start of treatment and are generally expected to subside with continued use as the skin adapts.

Less frequently, severe reactions have been documented under the Immune system disorders class. These serious adverse reactions, classified as Frequency Not Known (cannot be estimated), include anaphylaxis and facial swelling (angioedema).

Safety Restrictions

Official labeling defines specific safety constraints for use. The preparation must not come into contact with the eyes, mouth, nostrils, or any mucous membranes. Additionally, users must avoid excessive exposure to sunlight or ultraviolet (UV) light. The substance is also documented to cause a bleaching effect on hair and colored fabric.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below is based strictly on the officially documented overdose statements found in government regulatory prescribing information for products containing topical benzoyl peroxide (such as Peroxiben).


Local Overdose (Excessive Topical Application)

Overdose Presentation Regulatory Guidance and Action
Severe Irritation Occurs if the gel is applied excessively, leading to the skin becoming excessively red and painful.
Action for Local Overdose Discontinue use immediately until the skin has fully recovered. The frequency of application should be reduced thereafter. Cold compresses may be used to provide relief.

Systemic Overdose (Accidental Ingestion)

Topical benzoyl peroxide is generally not absorbed in sufficient quantities to cause systemic toxicity through normal skin use. However, accidental ingestion of the product is considered a serious event and requires specific immediate action as outlined in regulatory documents.

Accidental Ingestion Action When to Seek Urgent Medical Help
Emergency First Aid Do not induce vomiting. The mouth should be washed.
Urgent Medical Help Medical assistance must be sought immediately in case of accidental ingestion. Consult the national Poison Control Center or a medical professional immediately.

Symptomatic and supportive management is the advised course of action following accidental ingestion. Always consult a doctor or pharmacist immediately if you have used more of the product than recommended, or if irritation persists even after reducing the frequency of use.

Therapeutic Uses of Peroxiben

What Peroxiben Treats: Main Uses and Benefits

Benzoyl Peroxide, the active ingredient in Peroxiben, is commonly used to help with the symptoms associated with the condition known as Acne Vulgaris. It is considered relevant in clinical settings for symptomatic management of acne.

This treatment is applied in addressing symptoms that cluster into patterns requiring supportive management, particularly manifestations of mild to moderate severity. It is used for managing both inflammatory lesions (such as papules and pustules) and non-inflammatory lesions (like blackheads and whiteheads) that commonly appear on the face, chest, and back.

The treatment's primary role supports the long-term management of the condition. Applied in settings where recurrent or episodic manifestations are the primary concern, it supports patients during episodes of heightened discomfort and contributes to easing the overall symptom load over time. It provides supportive relief when symptoms interfere with routine activities.


“This medication is applied in managing symptoms related to inflammatory or irritative states, supporting symptomatic management in conditions characterized by periods of heightened symptoms.”


Quick Fact: Relief for Recurrent Blemishes The treatment is relevant for conditions characterized by periods of heightened symptoms and supports the patient's efforts in managing recurrent or episodic manifestations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Peroxiben? — Official Regulatory Information

The eligibility for using Peroxiben (Benzoyl Peroxide topical gel) is strictly defined by regulatory documents based on population and physiological status.

Contraindications (Must Not Use)

Use is contraindicated for patients with a known hypersensitivity or allergy to Benzoyl Peroxide or any of the product's excipients. Additionally, the gel must not be applied to areas of damaged skin, including skin that is sunburnt, broken, or eczematous, to prevent excessive irritation.


Age and Reproductive Status Limitations

Population Group Regulatory Status
Children under 12 Not recommended; safety and effectiveness are not established.
Adults & Adolescents (12+) Approved for use in this age group for moderate acne vulgaris.
Older Adults (65+) Safety and efficacy have not been established.
Pregnancy Use is conditional; only administered if medically assessed as clearly necessary.
Lactation Use is permitted with caution; application to the chest area must be avoided.

Condition-Specific Eligibility

No specific restrictions regarding renal or hepatic impairment are typically documented in official labeling, as systemic absorption of topical Benzoyl Peroxide is minimal. However, use in patients with very sensitive skin is advised with special care.

What should I know about interactions with other medicines?

Interactions with Other Topical Products

Peroxiben (benzoyl peroxide) is a strong oxidizing agent, and its primary interactions involve local effects on the skin and chemical reactions with other topically applied agents. The most significant interaction is the risk of cumulative skin irritation and dryness.

Interacting Product Category Effect/Mechanism Regulatory Note
Other Topical Acne Agents Increased risk of irritation, peeling, and dryness. Avoid concurrent use with topical products that have strong drying, peeling, or abrasive properties.
Topical Retinoids (e.g., Tretinoin) Decreased efficacy of the retinoid due to oxidative degradation by benzoyl peroxide. Do not apply simultaneously. Some combination products are specially formulated to stabilize the ingredients.
Topical Sulfone Products (e.g., Dapsone) Chemical reaction resulting in temporary yellow or orange discoloration of the skin and facial hair. Avoid simultaneous application. If both are necessary, use at separate times of day.
Alcohol-based Products Increased local skin irritation and drying effects. Avoid using astringents, toners, or other products containing high concentrations of alcohol.

No formal pharmacokinetic drug-drug interactions involving systemic absorption have been definitively established. Patients should be cautious with all concurrent topical products and should notify a healthcare professional about all medicines, supplements, or skincare products being used.

Mechanism of Action

Oxidative Bactericidal and Comedolytic Mechanism

The action of Peroxiben is driven by Benzoyl Peroxide (BPO), which functions as a localized oxidizing agent within the pilosebaceous unit. Upon penetration, BPO cleaves to generate highly reactive oxygen species (free radicals). This is a non-specific chemical interaction that directly oxidizes and damages the proteins and lipid membranes of the anaerobic bacteria, extbfCutibacterium acnes, resulting in cellular death ( extbfbactericidal action). This primary action reduces the microbial population and is consistent with a non-specific mechanism that is not typically associated with the emergence of bacterial resistance.

Simultaneously, the oxidative power exerts a extbfkeratolytic effect by breaking down the tough keratin and lipid bonds of the follicular obstruction ( extbfmicrocomedone). This accelerates the natural desquamation (shedding) of epithelial cells in the follicle lining, contributing to the physical clearance of the duct. By reducing the concentration of extitC. acnes and removing the physical obstruction, the overall inflammatory cascade is indirectly modulated. This limits the release of pro-inflammatory factors, resulting in a physiological decrease in localized immune cell activity and contributing to the resolution of localized erythema and edema.

Dosage and Administration Information

How Peroxiben is Used: Official Administration Guidelines

Peroxiben, a topical Benzoyl Peroxide gel, is strictly administered according to official guidelines to ensure standardized usage. This medication is solely intended for cutaneous use (external application to the skin) and is available in concentrations such as 2.5%, 5%, and 10% w/w.


Application Procedure and Frequency

Official labels recommend applying a small amount of the gel to the affected area. The strength and frequency of application are generally adjusted based on the individual's skin tolerance.

Feature Official Labeled Instruction
Preparation The affected area must be cleaned and thoroughly dried before application.
Frequency Application is typically started once daily (often in the evening), with the potential to increase to twice daily (morning and evening).
Technique Apply a thin layer of the gel. Hands must be washed thoroughly after application.

Usage Constraints and Duration

Specific instructions govern where and how the product can be applied. Contact must be strictly avoided with sensitive areas, including the eyes, lips, mouth, and any mucous membranes. Additionally, the product has a known bleaching effect and should not come into contact with hair or dyed fabrics.

Duration of Use: Improvement is generally observed after 4 to 6 weeks of consistent application. Treatment may need to be continued for a longer, sustained period to help maintain the effect.

Age-Specific Rules: The regimen is the same for adolescents (from 12 years of age) as for adults. Use in children under 12 years of age is generally not recommended as safety and efficacy have not been formally established in this population.

Recent Clinical Evidence

Evidence for Use in Mild to Moderate Acne Vulgaris

Peroxiben's active ingredient, Benzoyl Peroxide (BPO), was evaluated in research exploring its application in conditions characterized as mild to moderate acne vulgaris. Research has explored how symptoms change over time through numerous Randomized Controlled Trials (RCTs). These short-term RCTs typically enrolled adolescents and adults, and the resulting data was monitored and synthesized in subsequent systematic reviews and meta-analyses.

Research examined outcomes related to physical discomfort, which primarily focused on lesion counts. Studies monitored changes in the total number of acne lesions, specifically tracking inflammatory and non-inflammatory lesions. Researchers also used standardized investigator-assigned scores, known as Global Assessment Scores, to provide an overall rating of the skin condition during the study period.

In regulatory reviews, the long history of data contributed to the FDA's designation of BPO as Generally Recognized as Safe and Effective (GRASE) for over-the-counter use. Evidence highlights what is known, and these findings reflect group patterns observed in the studies, although the quality of evidence varies across studies.

Comparison of Studies Against Placebo

Clinical trials exploring short-term symptom changes was evaluated in settings comparing the BPO gel against a placebo or a non-medicated vehicle control. This research primarily focused on episodes where symptoms become more noticeable.

The findings describe patterns observed in the studies over the short-term duration when comparing BPO to the inactive control. These observations were based on the measured changes in lesion counts and the differences observed in overall skin severity scores assigned by the investigators. Data show patterns related to measured changes between the active treatment group and the control group in some trials.

Long-term Follow-up and Maintenance Studies

Most efficacy data focuses on defined time intervals of 8 to 12 weeks. This means that limited information for long-term outcomes exists for observations extending after several months or a full year of use.

Studies observing responses over extended periods are still emerging. While some open-label, randomized trials studies monitored treatment course for up to a year, long-term outcomes are not fully established by the same high-certainty evidence that is typically preferred for short-term efficacy. Research provides insight into short-term changes, but further study is ongoing to fully characterize the durability of observations.

Evidence in Key Study Populations

The populations studied in the primary research include adolescents and adults who have acne characterized as mild to moderate. Research examined individuals aged 12 years and older, reflecting common usage patterns.

The results apply only to the populations studied. Data for certain groups remain insufficient, meaning there is limited information available for understanding the treatment course in older adults or individuals whose acne is characterized as severe. Subgroup findings are also uncertain when attempting to draw conclusions beyond the specific populations that participated in the main clinical trials.

What Research Currently Considers Uncertain

The evidence highlights what is known and what is still uncertain regarding Peroxiben's active ingredient. Current systematic reviews suggest that the certainty remains low for many specific comparative outcomes. This description relates to the evidence quality across studies, not the treatment's safety profile.

Research limitation frames indicate that evidence quality varies across studies, often due to factors like modest sample sizes or differing trial designs. Follow-up durations were limited, restricting the data available for long-term outcomes. Comparative evidence is lacking for certain head-to-head comparisons against all available topical prescription agents, and further research is ongoing to address these gaps in the broader evidence landscape.

Frequently Asked Questions (FAQ)

Common questions about Peroxiben (FAQ)


Q: Is Peroxiben used for body acne or just face issues?

Official guidelines describe Peroxiben as a medication for cutaneous use, meaning it is applied externally to the skin of the affected area(s). Official instructions do not impose a restriction limiting use to the face only. However, specific sensitive areas, including the eyes, lips, mouth, nostrils, and any mucous membranes, must be strictly avoided.

Q: If I miss a day of using Peroxiben, what does official guidance say?

The official guidance recommends that if a dose is missed, it can be applied when remembered. However, if it is nearly time for the next application, the guidance suggests skipping the missed dose. It is explicitly advised not to use a double amount to compensate for a missed application.

Q: Are there any known issues with using Peroxiben and makeup at the same time?

Official patient guidance advises exercising caution with cosmetic use while undergoing treatment. It suggests minimizing makeup and choosing water-based products that are labeled as non-comedogenic (products less likely to block pores). Patient guidance also suggests removing makeup thoroughly before applying the medication.

Q: What is the official guidance if someone accidentally swallows Peroxiben?

Peroxiben is strictly for topical application. Official safety information states that the medicine may be harmful if it is swallowed. If accidental ingestion occurs, official guidance outlines the necessity of contacting a poison control center or seeking emergency medical help immediately.

Q: Why is Peroxiben often sold over the counter in some places but requires a prescription in others?

Benzoyl Peroxide, the active ingredient, is often available over-the-counter (OTC) as a single ingredient, based on its classification as Generally Recognized as Safe and Effective (GRASE) by authorities like the FDA. When Benzoyl Peroxide is formulated in combination with other drugs, such as an antibiotic or a retinoid, the resulting combination product usually requires a prescription.

Q: What do official sources say about what happens if I stop using Peroxiben suddenly?

Official guidance indicates that treatment is recommended to be continued for a sustained period to maintain the effect. Regulatory-associated patient information notes that upon discontinuation, the acne condition may reoccur or experience a relapse, which may necessitate restarting treatment.

Q: How is Peroxiben packaged, and why does that matter for the product?

Official regulatory documents set strict storage requirements for the product, such as storing it below a specific temperature (e.g., 30 C) and ensuring it is not frozen. The purpose of these requirements is to help maintain the chemical stability and integrity of the product throughout its shelf life.

Q: Does Peroxiben affect the skin's barrier function?

The drying, peeling, and irritation that Peroxiben may cause are related to its strong oxidizing properties. These common effects are understood to temporarily influence the structure and hydration levels of the skin's surface.

Q: What is the purpose of patch testing before starting Peroxiben, if any?

Official product information contraindicates the use of the preparation for patients with a known hypersensitivity or allergy to Benzoyl Peroxide. Some patient information advises checking for a localized skin reaction on a small area before the first full application as a way to identify a potential allergic reaction.

Q: How does Peroxiben differ from a prescription medicine for similar issues?

Peroxiben, as a standalone product, contains only the active ingredient Benzoyl Peroxide (monotherapy). Many prescription products for similar skin conditions contain Benzoyl Peroxide in combination with another drug, such as a topical antibiotic or a topical retinoid, which is the main difference.

Q: Can Peroxiben be used on sensitive skin areas?

Official safety labeling strictly defines that the medication must be kept away from sensitive body areas, including the eyes, lips, mouth, nostrils, and any mucous membranes. Additionally, use in individuals who have very sensitive skin is advised to be done with special care.

Q: What is the expected timeline for maximum results from Peroxiben?

While the onset of improvement is generally noted after 4 to 6 weeks of consistent application, official patient information may indicate that the full or maximum expected result can take a longer period to achieve. This often ranges from 2 to 4 months of sustained use.

Q: Can Peroxiben be used alongside general moisturizers or sunscreens?

Yes, official patient guidance recommends using a non-irritating, fragrance-free, water-based moisturizer if dryness or peeling becomes bothersome. As the medication may increase sun sensitivity, patient guidance strongly advises the use of a broad-spectrum sunscreen for protection.

Q: Are there any specific cleansers that official sources advise against using with Peroxiben?

Yes. Official patient information advises against using any other topical products that have strong drying, peeling, or abrasive properties. This includes abrasive cleansers or products that contain high concentrations of alcohol.

Q: Are there different strengths of Peroxiben available, and what are they used for?

The product is generally available in concentrations such as 2.5%, 5%, and 10%. Regulatory documentation states that the concentration used and the frequency of application are officially adjusted based on the individual's skin tolerance and the condition being managed.

Q: What is the official information regarding Peroxiben and potential skin bleaching?

Official regulatory documents explicitly state that the product is known to cause a bleaching effect on hair and colored fabric, and contact with these materials must be avoided. The official safety labeling, however, does not include a claim regarding the permanent bleaching or hypopigmentation of the skin itself.

Q: Are there specific symptoms that indicate I should stop using Peroxiben?

Yes. Official safety information lists serious adverse reactions that necessitate seeking immediate medical attention. These signs of a serious adverse reaction include hives, trouble breathing, or swelling of the face, lips, eyes, or tongue.

Q: Does Peroxiben cause purging, and what is that term usually describing?

Official regulatory documentation notes that common adverse effects, such as irritation and redness, are more likely to appear when a user first starts treatment. This initial increase in visible symptoms is the phenomenon often described by patients as 'purging,' which is generally expected to subside as the skin adapts with continued use.

Q: What is the difference between Peroxiben and a product that only contains salicylic acid?

Peroxiben's active ingredient acts as both a bactericide and a keratolytic (peeling agent) through an oxidizing mechanism. Medical discussions related to this mechanism indicate that the keratolytic effects that help clear pore blockages are generally considered milder compared to the dedicated exfoliating action of a product containing only salicylic acid.

Q: Is Peroxiben described as being safe for all skin types in regulatory documents?

The active ingredient is designated as Generally Recognized as Safe and Effective (GRASE) for OTC use. However, use is explicitly contraindicated on damaged skin, such as skin that is eczematous or sunburnt. Official guidance also advises using the product with special care on individuals who have very sensitive skin.

Q: Can Peroxiben be used as a spot treatment, according to its labeling?

Official instructions for application are to apply a thin layer of the gel to the entire affected area after cleansing and drying the skin. This instruction for coverage is intended to manage the overall condition of the area, rather than targeting only individual spots.

Q: Does the time of day I apply Peroxiben affect its function?

Official instructions state that application is typically started once daily, often in the evening, with the possibility of increasing to twice daily. While the documentation does not provide a direct scientific rationale, this timing may be recommended to allow the skin to adapt and to help minimize potential irritation from sun exposure.

Q: How can I safely reduce the common irritation I experience when starting Peroxiben?

Official guidelines recommend starting application once daily and then gradually increasing the frequency only if the skin shows tolerance to the product. Reducing the frequency of use temporarily is the principal method advised in official guidelines for managing irritation and dryness.

How should Peroxiben be stored and disposed of?

How to Store and Dispose of Peroxiben

The storage and disposal of Peroxiben (Benzoyl Peroxide gel) must adhere strictly to the conditions specified in official regulatory labeling to maintain the product's integrity and safety.

Storage Requirements

The product must be stored at a temperature below 30 C or below 25 C for certain formulations. It is explicitly required that the gel must not be frozen.

For child safety, the medication must be kept out of the sight and reach of children at all times.

Stability and Disposal

The established in-use shelf life after the initial opening is 6 months, provided the specified storage temperature is maintained.

When disposing of unused or expired product, no special requirements for disposal are officially noted. Consequently, any waste material must be discarded in accordance with local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Peroxiben found in:

A-Z Index: